Tag: IT

Dairy MAX's "Diner Tycoon" Is Out Now, Aiming To Put Dairy Back On The Map For Gen Z GRAND PRAIRIE, Texas, July 18, 2025 /PRNewswire/ --...

Collaboration with Epic is first phase of a multiyear project that will include multiple technology partners CHICAGO, July 18, 2025 /PRNewswire/ -- Long recognized as...

Experienced Surgeon, Compassionate Team, Whole-Person Care. MONTREAL, July 18, 2025 /CNW/ - As access to care becomes increasingly complex, the Dr Benoit Benoit Orthopedic Clinic,...

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter

Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter 

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing...

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing...

The Manufacturing Execution System Companies Quadrant offers an in-depth analysis of the global Manufacturing Execution System (MES) market, highlighting key players, technological advancements, and emerging trends. Over 100 companies were evaluated, with the top 16 recognized as quadrant leaders. MES software is crucial in monitoring production lifecycles, integrating with ERP to boost efficiency. Market growth is fueled by mass production demands, IT and OT integration, and automation advancements. Key segments include offerings, deployment modes, and industry applications. Leading companies like Siemens, Dassault Systèmes, and SAP SE drive innovation through R&D and strategic partnerships, positioning themselves at the forefront of this dynamic market.

The Manufacturing Execution System Companies Quadrant offers an in-depth analysis of the global Manufacturing Execution System (MES) market, highlighting key players, technological advancements, and emerging trends. Over 100 companies were evaluated, with the top 16 recognized as quadrant leaders. MES software is crucial in monitoring production lifecycles, integrating with ERP to boost efficiency. Market growth is fueled by mass production demands, IT and OT integration, and automation advancements. Key segments include offerings, deployment modes, and industry applications. Leading companies like Siemens, Dassault Systèmes, and SAP SE drive innovation through R&D and strategic partnerships, positioning themselves at the forefront of this dynamic market.

The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skilled professional shortage. Key players include Beckton Dickinson, Teleflex, and ICU Medical, known for expanding portfolios through strategic acquisitions and innovations. The quadrant evaluates companies based on revenue, growth strategies, and product footprint across device types and applications.

The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skilled professional shortage. Key players include Beckton Dickinson, Teleflex, and ICU Medical, known for expanding portfolios through strategic acquisitions and innovations. The quadrant evaluates companies based on revenue, growth strategies, and product footprint across device types and applications.

This latest partnership expands the commercial overhead, residential garage door, and fireplace services available to customers in the Central Alabama area DALLAS, July 18, 2025...

CRYSTAL, Minn., July 18, 2025 /PRNewswire/ -- The U.S. Postal Service issued the schooner stamped card today at the Minnesota Stamp Expo. This new stamped...

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global technetium-99m market is witnessing substantial...

DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025...